本页面由Tiger Trade Technology Pte. Ltd.提供服务

Arcus Biosciences Inc.

22.51
-1.8300-7.52%
盘后:22.510.00000.00%19:30 EDT
成交量:139.35万
成交额:3,185.24万
市值:28.66亿
市盈率:-5.83
高:24.01
开:23.87
低:22.46
收:24.34
52周最高:31.74
52周最低:15.38
股本:1.27亿
流通股本:8,983.64万
量比:1.08
换手率:1.55%
股息:- -
股息率:- -
每股收益(TTM):-3.8641
每股收益(LYR):-3.2900
净资产收益率:-90.82%
总资产收益率:-30.39%
市净率:6.18
市盈率(LYR):-6.84

数据加载中...

2024/01/30

重要事件披露

Form 8-K - Current report
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/08

重要事件披露

Form 8-K - Current report
2023/09/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/07

重要事件披露

Form 8-K - Current report
2023/07/06

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/28

重要事件披露

Form 8-K - Current report
2023/06/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities